Finance

Lists
Why is 301301 up 2,19%?
Dive Deeper
301301:SHE
Yili Chuanning Biotechnology Co Ltd
7,95 CNY
+2,19%
(+0,17) 1D
16 ოქტ, 12:20:19 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 301301...
Open
7,85 CNY
High
7,97 CNY
Low
7,82 CNY
Mkt. cap
17,79 მლრდ.
Avg. vol.
12,28 მლნ.
Volume
6,27 მლნ.
Dividend
2,18%
Quarterly dividend
0,04 CNY
Ex-dividend date
29 აპრ. 2026
P/E ratio
31,01
52-wk high
12,90 CNY
52-wk low
7,69 CNY
EPS
0,26 CNY
Shares outstanding
2,23 მლრდ.
No. of employees
3 ათ.
Open
7,85 CNY
High
7,97 CNY
Low
7,82 CNY
Mkt. cap
17,79 მლრდ.
Avg. vol.
12,28 მლნ.
Volume
6,27 მლნ.
Dividend
2,18%
Quarterly dividend
0,04 CNY
Ex-dividend date
29 აპრ. 2026
P/E ratio
31,01
52-wk high
12,90 CNY
52-wk low
7,69 CNY
EPS
0,26 CNY
Shares outstanding
2,23 მლრდ.
No. of employees
3 ათ.
News stories
From web sources and news partners
marketscreener.com
marketscreener.com
·
17 წუთის წინ
S&P 500 index rose slightly after Stockholm exchange close Thursday
Investor's Business Daily
Investor's Business Daily
·
1 საათის წინ
Futures Mixed; Anthropic Value, Tesla Roadster In Focus
About Yili Chuanning Biotechnology Co Ltd
CEO-
Employees3,13 ათ.
Founded10 დეკ. 2010
Headquarters-
Sector-
Websiteklcnsw.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
1,09 მლრდ.
1,18 მლრდ.
1,09 მლრდ.
1,00 მლრდ.
Cost of goods sold
775,99 მლნ.
981,03 მლნ.
836,67 მლნ.
720,54 მლნ.
Cost of revenue
775,99 მლნ.
981,03 მლნ.
836,67 მლნ.
720,54 მლნ.
Research and development expenses
16,00 მლნ.
18,85 მლნ.
22,09 მლნ.
17,74 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
56,83 მლნ.
4,30 მლნ.
64,17 მლნ.
35,39 მლნ.
Operating expense
75,86 მლნ.
45,95 მლნ.
103,10 მლნ.
73,21 მლნ.
Total operating expenses
851,85 მლნ.
1,03 მლრდ.
939,77 მლნ.
793,75 მლნ.
Operating income
235,55 მლნ.
153,30 მლნ.
154,73 მლნ.
209,48 მლნ.
Other non operating income
-10,94 მლნ.
9,26 მლნ.
-8,98 მლნ.
8,64 მლნ.
EBT including unusual items
192,27 მლნ.
186,91 მლნ.
138,71 მლნ.
198,60 მლნ.
EBT excluding unusual items
212,88 მლნ.
159,94 მლნ.
137,49 მლნ.
201,32 მლნ.
Income tax expense
35,94 მლნ.
29,47 მლნ.
28,69 მლნ.
34,53 მლნ.
Effective tax rate
18,69%
15,77%
20,68%
17,39%
Other operating expenses
1,01 მლნ.
27,22 მლნ.
17,15 მლნ.
18,07 მლნ.
Net income
156,53 მლნ.
157,62 მლნ.
110,73 მლნ.
166,78 მლნ.
Net profit margin
14,40%
13,35%
10,12%
16,62%
Earnings per share
-
-
-
-
Interest and investment income
897,08 ათ.
752,74 ათ.
674,20 ათ.
856,59 ათ.
Interest expense
-9,41 მლნ.
-3,00 მლნ.
-8,93 მლნ.
-9,39 მლნ.
Net interest expenses
-8,52 მლნ.
-2,25 მლნ.
-8,25 მლნ.
-8,54 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
370,98 მლნ.
295,77 მლნ.
297,20 მლნ.
356,20 მლნ.
Gain or loss from assets sale
352,14 ათ.
-345,96 ათ.
-
-
AI content may include mistakes. Learn more
Google აპები